Advice
About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers, and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
Development of this briefing
This briefing was developed for NICE by King's Technology Evaluation Centre. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality assured and approved for publication.
Project team
-
King's Technology Evaluation Centre (KiTEC), King's Health Partners
-
Medical Technologies Evaluation Programme, NICE
Peer reviewers and contributors
-
Anastasia Chalkidou, Health Technology Assessor, KiTEC
-
Robert Dowling, Health Technology Assessor, KiTEC
-
Tiago Rua, Health Economist, KiTEC
-
Muralikrishnan R. Kartha, Health Economist, KiTEC
-
Stephen Keevil, Director, KiTEC
-
Cornelius Lewis, Director, KiTEC
-
Viktoria McMillan, Centre Manager, KiTEC
Specialist commentators
The following specialist commentators provided comments on a draft of this briefing:
-
Dr John Logue, Clinical Oncologist, The Christie NHS Foundation Trust
-
Dr Simon Russell, Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust
-
Dr Joshua Mason, Medical Physicist, St. James's University Hospital, Leeds
-
Robert Johnstone, Medical Physicist, Guy's and St Thomas' NHS Foundation Trust
Copyright
© National Institute for Health and Care Excellence 2014. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.
ISBN: 978-1-4731-0870-7